OnKure

OnKure Therapeutics

Boulder, United States · $259.0M raised

Headquarters
Boulder, Colorado
Total Funding
$259.0M
Last Round
$150.0M Corporate RoundMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancers and vascular anomalies underserved by available therapies. Using a structure-based drug design platform, OnKure builds a pipeline of small molecule drugs designed to achieve optimal efficacy and tolerability by selectively targeting specific mutations that drive cancer and other diseases. The company aims to become a leader in targeting oncogenic PI3Kα, with multiple programs designed for best-in-class targeting of this key oncogene.

Summary

OnKure is a Biotech company based in Boulder, United States. It has raised $259.0M in total across 3 rounds, most recently a $150.0M Corporate Round in Mar 2026. Investors include Surveyor Capital, BVF Partners and RA Capital Management.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMar 2026
$150.0M

Sign up to see all 3 events

Funding: Series B through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OnKure on Indexed.vc
<a href="https://indexed.vc/companies/onkure"><img src="https://indexed.vc/api/badge/company/onkure" alt="OnKure on Indexed.vc" width="260" height="76" /></a>